I couldn't believe the "limitless" pill was real

Learn Faster <Chase@graylingsmarterself.com> Thu, 26 March 2015 00:26 UTC

Return-Path: <ChaseHouston@cust26673-1.graylingsmarterself.com>
X-Original-To: ietfarch-krb-wg-archive@ietfa.amsl.com
Delivered-To: ietfarch-krb-wg-archive@ietfa.amsl.com
Received: from localhost (ietfa.amsl.com [127.0.0.1]) by ietfa.amsl.com (Postfix) with ESMTP id B0EF71A0199 for <ietfarch-krb-wg-archive@ietfa.amsl.com>; Wed, 25 Mar 2015 17:26:00 -0700 (PDT)
X-Virus-Scanned: amavisd-new at amsl.com
X-Spam-Flag: NO
X-Spam-Score: 0.788
X-Spam-Level:
X-Spam-Status: No, score=0.788 tagged_above=-999 required=5 tests=[BAYES_50=0.8, SPF_HELO_PASS=-0.001, SPF_PASS=-0.001, T_RP_MATCHES_RCVD=-0.01] autolearn=ham
Received: from mail.ietf.org ([4.31.198.44]) by localhost (ietfa.amsl.com [127.0.0.1]) (amavisd-new, port 10024) with ESMTP id j45OBwNtNE3Q for <ietfarch-krb-wg-archive@ietfa.amsl.com>; Wed, 25 Mar 2015 17:25:58 -0700 (PDT)
Received: from cust26673-1.graylingsmarterself.com (cust26673-1.graylingsmarterself.com [78.159.152.99]) by ietfa.amsl.com (Postfix) with ESMTP id 6D3CB1A0143 for <krb-wg-archive@lists.ietf.org>; Wed, 25 Mar 2015 17:25:56 -0700 (PDT)
Message-ID: <Java.891590.KZ0vf40M1pYzn.20150325170845512@cust26673-1.graylingsmarterself.com>
Date: Wed, 25 Mar 2015 17:25:55 -0700
From: Learn Faster <Chase@graylingsmarterself.com>
To: <krb-wg-archive@lists.ietf.org>
Reply-to: <Chase@graylingsmarterself.com>
Subject: I couldn't believe the "limitless" pill was real
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7bit
MIME-Version: 1.0



The REAL Limitless Pill.  Fact or Fiction?

Join the discussion and judge for yourself now
http://www.graylingsmarterself.com/malachite/397/filmily_keesters-4988/apprehension.php

+-+-+-+-+-++-+-+-+-+-++-+-+-+-+-++-+-+-+-+-++-+-+-+-+-++-+-+-+-+-++-+-+-+-+-++-+-+

Your brain could be razor sharp and take you to places you never thought existed

See how: http://www.graylingsmarterself.com/malachite/397/filmily_keesters-4988/apprehension.php












N3C | News | Videos | Opinions | Travel | #HASHTAG








Right Tuller and Travlers has sent this message.  Stop messages here http://www.graylingsmarterself.com/heckles-6060-spacer.html

2103 13th Ave North
Grand Forks, ND 58203




The actress had planned to have the surgery, but went ahead with it earlier than expected after a test indicated she could be at risk for a tumor.

I went through what I imagine thousands of other women have felt, she wrote in todays New York Times. I told myself to stay calm, to be strong, and that I had no reason to think I wouldnt live to see my children grow up and to meet my grandchildren.

The surgery called, laparoscopic bilateral salpingo-oophorectomy, meant removing her ovaries and Fallopian tubes as a preventative measure, which effectively put the actress into early menopause.

Experts say they appreciate how the actress and humanitarian has shined a light on the choice that thousands of women are forced to decide in their lifetime whether to go through a life-changing surgery or live with the risk. We talked to a number of experts to look at the surgery Jolie underwent and its effects.

Who Should Consider Surgery?

After undergoing a bilateral mastectomy two years ago, Angelina Jolie wrote in a previous op-ed in the New York Times that she had tested positive for the BRCA1 gene mutation that had left her at a higher risk for both breast and ovarian cancer. Combined with her family history, Jolie said in her op ed today, her doctors recommended she have the surgery to remove her ovaries early, in order to significantly lower her risk of ovarian cancer.

Experts say each woman who tests positive for the BRCA gene mutation (either BRCA1 or BRCA2) or who has a family history of either breast or ovarian cancer should have a discussion with their doctor about preventative measures, including possibly surgery.

Dr. Robert DeBernardo, a gynecologic oncologist in the Department of Gynecologic Oncology at Cleveland Clinic Ob/Gyn & Womens Health Institute, said women with a BRCA mutation have an up to 40 percent chance of developing the cancer, depending on whether they have the BRCA1 or BRCA 2 mutation, compared with a 1.3 percent chance for all women, according to the National Cancer Institute.

The National Cancer Institute found that having a BRCA gene mutation can lead to an 11 to 40 percent chance of ovarian cancer over a woman's lifetime.

This is a cancer we cant detect until its advanced, DeBernardo said. Once my patients understand the risks, they [often] opt to have the surgery.

////////////




!!!###